Joseph J. Oleynek

537 total citations
14 papers, 449 citations indexed

About

Joseph J. Oleynek is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Joseph J. Oleynek has authored 14 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Joseph J. Oleynek's work include Receptor Mechanisms and Signaling (4 papers), Adenosine and Purinergic Signaling (3 papers) and Ion channel regulation and function (3 papers). Joseph J. Oleynek is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Adenosine and Purinergic Signaling (3 papers) and Ion channel regulation and function (3 papers). Joseph J. Oleynek collaborates with scholars based in United States and Australia. Joseph J. Oleynek's co-authors include Roger J. Hill, W. Ross Tracey, Delvin R. Knight, Scott P. Kennedy, Jimmy Kong, Christopher F. Hoth, William P. Magee, Kaushik D. Meisheri, Dexue Sun and David M. Sedlock and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Journal of Lipid Research.

In The Last Decade

Joseph J. Oleynek

14 papers receiving 437 citations

Peers

Countries citing papers authored by Joseph J. Oleynek

Since Specialization

Citations

This map shows the geographic impact of Joseph J. Oleynek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph J. Oleynek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph J. Oleynek more than expected).

Fields of papers citing papers by Joseph J. Oleynek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph J. Oleynek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph J. Oleynek. The network helps show where Joseph J. Oleynek may publish in the future.

Co-authorship network of co-authors of Joseph J. Oleynek

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph J. Oleynek. A scholar is included among the top collaborators of Joseph J. Oleynek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph J. Oleynek. Joseph J. Oleynek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	The hydrophobic tunnel present in LOX-1 is essential for oxidized LDL recognition and binding 2008 ·Journal of Lipid Research ·Omar L. Francone, Meihua Tu, Lori Royer, Jian Zhu, Kimberly A. Stevens, Joseph J. Oleynek, Zhiwu Lin, (unknown), Thomas Sand, Yi Luo, Christopher D. Kane	21
2	The synthesis of highly potent, selective, and water-soluble agonists at the human adenosine A3 receptor 2006 ·Bioorganic & Medicinal Chemistry Letters ·Michael P. DeNinno, Hiroko Masamune, (unknown), Kenneth J. DiRico, (unknown), John B. Etienne, (unknown), Scott P. Kennedy, Delvin R. Knight, Jimmy Kong, Joseph J. Oleynek, W. Ross Tracey, Roger J. Hill	10
3	NovelN⁶-substituted adenosine 5′-N-methyluronamides with high selectivity for human adenosine A₃receptors reduce ischemic myocardial injury 2003 ·American Journal of Physiology-Heart and Circulatory Physiology ·W. Ross Tracey, William P. Magee, Joseph J. Oleynek, Roger J. Hill, Andrew H. Smith, D. M. Flynn, Delvin R. Knight	42
4	3‘-Aminoadenosine-5‘-uronamides: Discovery of the First Highly Selective Agonist at the Human Adenosine A ₃ Receptor 2002 ·Journal of Medicinal Chemistry ·Michael P. DeNinno, Hiroko Masamune, (unknown), Kenneth J. DiRico, (unknown), John B. Etienne, (unknown), Scott P. Kennedy, Delvin R. Knight, Jimmy Kong, Joseph J. Oleynek, W. Ross Tracey, Roger J. Hill	54
5	Expression of the Rat Adrenomedullin Receptor or a Putative Human Adrenomedullin Receptor Does Not Correlate with Adrenomedullin Binding or Functional Response 1998 ·Biochemical and Biophysical Research Communications ·Scott P. Kennedy, Dexue Sun, Joseph J. Oleynek, Christopher F. Hoth, Jimmy Kong, Roger J. Hill	80
6	Relative Importance of Adenosine A1and A3Receptors in Mediating Physiological or Pharmacological Protection from Ischemic Myocardial Injury in the Rabbit Heart 1998 ·Journal of Molecular and Cellular Cardiology ·Roger J. Hill, Joseph J. Oleynek, William P. Magee, Delvin R. Knight, W. Ross Tracey	48
7	Cloning, Expression and Pharmacological Characterization of Rabbit Adenosine A1 and A3 Receptors 1997 ·Journal of Pharmacology and Experimental Therapeutics ·Roger J. Hill, Joseph J. Oleynek, Christopher F. Hoth, (unknown), Weifan Weng, Ronald T. Wester, W. Ross Tracey, Delvin R. Knight, Richard Buchholz, Scott P. Kennedy	31
8	Antimycins, Inhibitors of ATP-Citrate Lyase, from a Streptomyces sp. 1997 ·The Journal of Antibiotics ·Colin J. Barrow, Joseph J. Oleynek, (unknown), Hao Sun, Paul V. Kaplita, David M. Sedlock, Amanda M. Gillum, Christopher C. Chadwick, Raymond Cooper	50
9	AMPA (amino-3-hydroxy-5-methylisoxazole-4-propionic acid) Receptors in human brain tissues 1995 ·Journal of Receptors and Signal Transduction ·David G. Sawutz, Douglas S. Krafte, Joseph J. Oleynek, Brian Ault	7
10	Anthrones, naturally occurring competitive inhibitors of adenosine‐triphosphate‐citrate lyase 1995 ·Drug Development Research ·Joseph J. Oleynek, Colin J. Barrow, (unknown), David M. Sedlock, Dennis J. Murphy, Paul V. Kaplita, Hao Sun, Raymond Cooper, Amanda M. Gillum, Christopher C. Chadwick	16
11	WIN 64821, a novel neurokinin antagonist produced by an Aspergillus sp. 1994 ·The Journal of Antibiotics ·Joseph J. Oleynek, David M. Sedlock, Colin J. Barrow, Kenneth C. Appell, Frances M. Casiano, Dean A. Haycock, Susan J. Ward, Paul V. Kaplita, Amanda M. Gillum	32
12	Role of protein sulfation in vasodilation induced by minoxidil sulfate, a K+ channel opener. 1991 ·Journal of Pharmacology and Experimental Therapeutics ·Kaushik D. Meisheri, Joseph J. Oleynek, Lynn Puddington	15
13	A sensitive in vitro functional assay to detect K+ — channel-dependent vasodilators 1990 ·Journal of Pharmacological Methods ·Kaushik D. Meisheri, (unknown), Joseph J. Oleynek	12
14	Characterization of K+ channel-dependent as well as -independent components of pinacidil-induced vasodilation. 1990 ·Journal of Pharmacology and Experimental Therapeutics ·Kaushik D. Meisheri, (unknown), Suresh Purohit, (unknown), Sajida Khan, Joseph J. Oleynek	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact